DAIC

JANUARY 18, 2024

Highlights from "Addressing Structural Racism Through Public Policy Advocacy: A Policy Statement from the American Heart Association" include: - During the past few years, the largest increases in cardiovascular disease deaths were among Asian, Black and Hispanic adults in the U.S. is tied to structural discrimination. -

Cardiovascular Disease 109

Cardiovascular Disease Health Disparities Education Public Health 109

DAIC

MARCH 28, 2025

v As cardiovascular disease (CVD) continues to rise globally, vi the need for advanced diagnostic technologies like cardiac CT angiography (CCTA) becomes increasingly critical. vii Similarly, recent increases in Medicare reimbursement rates for CCTA are a positive step towards making this technology more accessible.

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

Frontiers in Cardiovascular Medicine

FEBRUARY 19, 2025

Cardiovascular diseases (CVDs), characterized by a high incidence rate and high mortality, have become the leading cause of death globally. CVDs include coronary heart disease, stroke, hypertension, and peripheral vascular diseases. In China, the death rate of CVDs ranks the first in all major diseases.

Myocardial Infarction 52

Myocardial Infarction Quality of Life Heart Transplant Ischemia 52

DAIC

DECEMBER 5, 2024

With this new funding, Cleerly will continue to scale its commercial growth and clinical evidence generation, helping health care professionals improve outcomes for patients across the coronary care pathway. Barclay continued, “Cardiovascular disease is the #1 cause of death globally and costs our country $422B annually.

Coronary Artery Disease 52

Coronary Artery Disease Medicare Plaque Technology 52

Frontiers in Cardiovascular Medicine

APRIL 4, 2024

On this state of the art, we summarize the available literature on the effectiveness of virtual reality on various physical and psychological outcomes in patients with atherosclerotic cardiovascular disease.

Cardiovascular Disease 49

Cardiovascular Disease Cardiac Rehabilitation Interventional Cardiology Technology 49

DAIC

MAY 14, 2024

The collaboration seeks to provide access to emerging technologies, like Medis QFR, while also reducing complexity in the cath lab to improve the operating environment for clinicians. In the assessment of coronary artery disease, QFR represents a significant advancement in how efficiently it can provide critical insights.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

DAIC

FEBRUARY 24, 2025

Cardiovascular disease (CVD) remains the leading cause of death in the U.S. By enabling the decisive shift from a reactive to a proactive cardiology model, this technology doesnt just improve patient outcomes it is also helping keep cardiovascular care sustainable and affordable. That future isnt decades away.

Hospital 52

Hospital Cardiovascular Disease Heart Failure Heart attacks 52

DAIC

JUNE 14, 2024

Positron joins forces with the coalitions founding members, Bracco Diagnostics , CDL Nuclear Technologies and Siemens Healthcare who have come together to promote federal policies that advance health outcomes for patients with cardiovascular disease and improve the availability of cardiac PET diagnostics throughout the United States.

Reimbursement 105

Reimbursement Technology Innovation Education 105

DAIC

JULY 10, 2024

In a room of 20 people, it’s likely that about 10 of them, or half, will presently have some form of cardiovascular disease (CVD). CVD is among the most prevalent diseases in the U.S., This includes artificial intelligence (AI), remote monitoring, virtual care, and other emerging technological advancements.

Technology 106

Technology Best Practices AFIB Patient Care 106

DAIC

JUNE 25, 2024

HHNM will use the Allia IGS Pulse system in its cardiac electrophysiology (EP) lab to plan, guide and monitor the outcomes of electrophysiological procedures, such as cardiac ablations, cardiac catherizations, transcatheter aortic valve replacements, balloon and coronary angioplasties and more. It’s an honor to have the U.S.’s

Electrophysiology 105

Electrophysiology Hospital Aortic valve Heart Disease 105

DAIC

FEBRUARY 28, 2024

The new scientific statement, “Use of Artificial Intelligence in Improving Outcomes in Heart Disease,” comes amid intense attention on AI as a way to improve cardiovascular disease prevention, detection, diagnosis and treatment. to ensure safety and effectiveness to mitigate harm as technologies rapidly evolve.

Best Practices 111

Best Practices Technology Cardiovascular Disease Stroke 111

DAIC

JULY 25, 2024

The IVI is working towards a transition to a new kind of wellness and health system fueled and empowered by digital technologies. This concept, reported the company, is about using technology to develop preventative approaches that are 10 times more impactful than the current available solution.

Technology 105

Technology Exercise Innovation Quality of Life 105

DAIC

JULY 15, 2024

Story Health has a proven track record of engaging patients with heart conditions in their health and improving outcomes,” said Guidehealth Co-founder and CEO Sanjay Doddamani, MD, who also is a cardiologist. This innovative approach directly integrates specialized cardiovascular care for high-risk patients with complex care plans.”

Technology 105

Technology Innovation Nursing Heart Failure 105

DAIC

OCTOBER 1, 2024

Food and Drug Administration (FDA) for its PlaqueIQ imaging analysis software to help physicians diagnose cardiovascular disease (CVD). I believe plaque quantification has the potential to greatly improve outcomes for patients while providing tremendous savings to the healthcare system.” Cardiovasc. 6 (3) (2019).

Cardiovascular Disease 52

Cardiovascular Disease Plaque Quality of Life Myocardial Infarction 52

DAIC

FEBRUARY 2, 2024

Cardiovascular disease is the leading cause of death globally - affecting millions of individuals and placing a significant burden on healthcare systems today. [1] million people in the United States by 2050 and 17.9 million in Europe by 2060. [2] Usman Siddiqui , Director of Electrophysiology. [5]

Electrophysiology 101

Electrophysiology Innovation AFIB Atrial Fibrillation 101

DAIC

OCTOBER 30, 2024

30, 2024 — HeartLung Technologies , a developer of AI tools for early detection of heart disease, lung cancer and other conditions announced that its AI-enabled Automated Cardiac Chambers Volumetry (AutoChamber) recently received “Breakthrough Medical Device” designation and marketing authorization from the U.S. “By

Cancer 45

Cancer Atrial Fibrillation Sudden Cardiac Death Heart Failure 45

DAIC

JULY 3, 2024

As this practice grows, the study highlights the critical need to monitor the effects of private equity acquisitions on quality of care and outcomes for patients with cardiovascular disease, as well as procedural utilization.

Outpatient 116

Outpatient Innovation Research Cardiovascular Disease 116

DAIC

APRIL 5, 2024

Following the close of the transaction, Johnson & Johnson MedTech will be a category leader in four high-growth cardiovascular segments. Shockwave is a leading, first-to-market provider of innovative intravascular lithotripsy (IVL) technology for the treatment of calcified CAD and PAD.

Cardiovascular Interventions 105

Cardiovascular Interventions Technology Innovation Angina 105

DAIC

APRIL 3, 2024

Now, with Caption AI technology, clinicians using Vscan Air SL handheld ultrasound will have access to real-time, step-by-step guidance to capture diagnostic-quality images and automated ejection fraction estimation to help inform clinical decisions across cardiac settings.

Ultrasound 81

Ultrasound Innovation Technology Cardiovascular Disease 81

DAIC

FEBRUARY 13, 2024

The introduction of Butterfly iQ3 includes a focus on higher precision capabilities for cardiovascular point-of-care ultrasound applications to inform complex decisions. said Andrei Stoica , PhD, Chief Technology Officer, Butterfly Network. milla1cf Tue, 02/13/2024 - 12:11 February 13, 2024 — Butterfly Network, Inc. ,

Ultrasound 105

Ultrasound Technology Innovation Anatomy 105

Circulation

NOVEMBER 11, 2024

Homophobia affects the mental health of the growing San Joaquin Valley (SJV) LGBTQ+ community leading to psychological distress and mental health concerns which can further lead to High Blood Pressure (HBP) and cardiovascular disease (CVD). Each student monitored 2 hypertensive and psychological distressed patients.

Health Disparities 40

Health Disparities Cardiovascular Disease Education Hypertension 40

DAIC

JUNE 12, 2024

Impacting 25 million people globally [1], deep venous disease results from venous thromboembolism, a condition that occurs when a blood clot forms in the vein [2]. It is the third most common cardiovascular disease [2]. Deep venous anatomy and obstructions can present a multitude of complexities and mechanical challenges.

Stents 105

Stents Stent Anatomy Ultrasound 105

DAIC

JUNE 12, 2024

Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.

Ultrasound 105

Ultrasound Cardio Oncology Technology Congenital Heart Disease 105

DAIC

MARCH 20, 2024

Improved patient safety with reduced radiation and contrast load Enhancing patient safety is a pivotal aspect of advanced cardiac imaging technology. By employing advanced scanning technology, healthcare providers can ensure patients undergo diagnostic procedures with minimized risks.

Technology 111

Technology Coronary Artery Disease Patient Care Private Practice 111

DAIC

MAY 30, 2024

Clinical success was defined as optimal stent expansion after final treatment with no in-hospital major adverse cardiovascular event (MACE). Shown here: Elixir Medical CEO Motasim Sirhan.

Stents 105

Stents Stent Peripheral Arterial Disease Cardiovascular Disease 105

DAIC

APRIL 3, 2024

This leap in early detection marks both a significant medical innovation and a new era in the detection of cardiovascular disease. As a result, many heart failure cases go undiagnosed until symptoms force a specialist or emergency hospital visit, leading to worse patient outcomes and exacerbated healthcare costs.2 In the U.S.,

Heart Failure 111

Heart Failure Cardiomyopathy AFIB Hospital 111

DAIC

MARCH 20, 2024

Not only does it validate the potential of our controllably-expandable polymer conduit, but it also means the world to patients seeking options for a number of cardiovascular diseases and conditions,” said Doug Bernstein , CEO, PECA Labs.

Pediatrics 105

Pediatrics Anatomy Technology Innovation 105

DAIC

JULY 25, 2024

mtaschetta-millane Thu, 07/25/2024 - 08:55 July 25, 2024 — Nanox, an innovative medical imaging technology company, announced that the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox.AI was highlighted in multiple scientific presentations at the 2024 Society of Cardiovascular Computed Tomography (SCCT) Annual Meeting. “We

Innovation 105

Innovation Coronary Artery Disease Hospital Cardiovascular Disease 105

DAIC

FEBRUARY 27, 2024

The first procedures, performed by leading physicians Saibal Kar , MD, FACC, FSCAI, (Program Director, Cardiovascular Disease Fellowship, Los Robles Health System , California, HCA Healthcare National Physician Director, Interventional Cardiology) and Devi Nair , MD, FACC, FHRS, (Director, Cardiac Electrophysiology Division, St.

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

American College of Cardiology

OCTOBER 27, 2024

New science presented at TCT 2024 and simultaneously published across the family of JACC Journals sheds light on topics including photon-counting detector-computed tomography (PCD-CT), new and emerging technologies for treating patients with cardiovascular diseases, fractional flow reserve (FFR) and resting full-cycle ratio for predicting myocardial (..)

Ultrasound 40

Ultrasound Ischemia Technology Cardiovascular Disease 40

DAIC

FEBRUARY 29, 2024

This year’s theme, “Advancing Cardiovascular Care for All” brings the latest practice-changing breakthroughs, along with top experts debating and discussing outcomes of highly-anticipated clinical trials. 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Cardiomatics

APRIL 5, 2024

In a world where technology reigns supreme, one of the most profound tools in medicine remains the irreplaceable electrocardiogram (ECG). As technology advances, so too does our ability to capture the heart’s rhythm with greater precision. 1] Arrhythmia Recognition: The Art of Interpretation, T.Garcia, D.Garcia.

Arrhythmia 92

Arrhythmia Tachycardia Bradycardia Electrocardiogram 92

ADN Center of Excellence

NOVEMBER 16, 2023

Why Cardiovascular Imaging Research & Core Labs Matter: Precision Diagnosis: These labs utilize cutting-edge imaging technologies like MRI, CT scans, and advanced echocardiography to enable precise diagnosis of cardiovascular diseases.

Innovation 52

Innovation Research Cardiovascular Imaging Cardiovascular Disease 52

ADN Center of Excellence

NOVEMBER 16, 2023

Why Cardiovascular Imaging Research & Core Labs Matter: Precision Diagnosis: These labs utilize cutting-edge imaging technologies like MRI, CT scans, and advanced echocardiography to enable precise diagnosis of cardiovascular diseases.

Innovation 52

Innovation Research Cardiovascular Imaging Cardiovascular Disease 52

DAIC

OCTOBER 4, 2024

This technology represents a critical advancement in early cardiac risk stratification, offering the potential for more targeted interventions through the simple addition of a single-lead ECG," said Dr. "Notably, the AI identified at-risk patients who had unremarkable results from traditional diagnostic tools, such as echocardiograms.

Heart Failure 52

Heart Failure Technology Heart attacks Heart Attack 52

Cardiometabolic Health Congress

JULY 25, 2024

Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease.

Education 100

Education Innovation Risk Factors Obesity 100

Cardiometabolic Health Congress

AUGUST 14, 2024

Real-World Cardiorenal Metabolic Management Cases Case Study 1: The Multidisciplinary Advantage A groundbreaking study compared outcomes between multi-ethnic patients treated by a multidisciplinary team (MDT) and those managed solely by primary care providers (PCPs). It further exemplifies the patient education and empowerment strategies.

Education 52

Education Innovation Reimbursement Cardiovascular Disease 52